Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Common Equity (2016 - 2025)

Historic Common Equity for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $4.4 million.

  • Biomerica's Common Equity fell 1327.73% to $4.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.4 million, marking a year-over-year decrease of 1327.73%. This contributed to the annual value of $4.1 million for FY2025, which is 3771.81% down from last year.
  • As of Q4 2025, Biomerica's Common Equity stood at $4.4 million, which was down 1327.73% from $5.2 million recorded in Q3 2025.
  • Biomerica's 5-year Common Equity high stood at $11.7 million for Q2 2023, and its period low was $4.1 million during Q2 2025.
  • In the last 5 years, Biomerica's Common Equity had a median value of $8.1 million in 2022 and averaged $7.7 million.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 12644.23% in 2021, then plummeted by 5035.29% in 2024.
  • Biomerica's Common Equity (Quarter) stood at $8.9 million in 2021, then dropped by 18.63% to $7.2 million in 2022, then grew by 29.55% to $9.4 million in 2023, then crashed by 45.5% to $5.1 million in 2024, then dropped by 13.28% to $4.4 million in 2025.
  • Its Common Equity was $4.4 million in Q4 2025, compared to $5.2 million in Q3 2025 and $4.1 million in Q2 2025.